ArticleMolecules (Basel, Switzerland)2022

In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus.

Sphamandla E Mtambo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.